Muscular Dystrophy Association Names Sharon Hesterlee, PhD, as President and Chief Executive Officer
New York, Nov. 12, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced the appointment of Sharon Hesterlee, PhD as President and Chief Executive Officer. Dr. Hesterlee ...
Whether kids like Sammy can achieve their dreams depends on whether Congress renews the Pediatric Priority Review Voucher ...
Here are eight jobs for the well-winter-prepped yard: Mulch acts like a blanket to keep the soil slightly warmer over winter, ...
The 100th birth anniversary of Dr Gamani Corea was commemorated on November 4, 2025, by the Gamani Corea Foundation (GCF).
Only two days after Bridgebio Pharma Inc. impressed investors with data from BBP-418 in limb-girdle muscular dystrophy type 2I/R9, the company was back at it again, this time reporting positive ...
Plant the tree and backfill with the excavated soil, then top with 1 to 2 inches of compost. Tamp the ground to remove air ...
All primary and secondary interim analysis endpoints in FORTIFY Phase 3 study successfully achieved with well-tolerated ...
Bridgebio Pharma (($BBIO)) has held its Q3 earnings call. Read on for the main highlights of the call. BridgeBio Pharma’s recent earnings call ...
Curvy Fashionista on MSN
7 Outfit Tricks Every Plus-Size Woman Should Know for a Slimmer Look
Fashion has always been about confidence and self-expression, yet many plus-size women find themselves struggling with ...
Bridgebio Pharma says it will seek U.S. approval of BBP-418 for LGMD2i after Phase 3 trial data showed a range of benefits for patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results